Sign in Subscribe
Pharmaceutical industry

Eli Lilly Partners with Spotfire to Accelerate Pharmaceutical Research

Strategic Insights

— 1 min read

Eli Lilly and Company, a global leader in pharmaceutical research, development, and manufacturing, has partnered with Spotfire, Inc. to implement a decision analytics infrastructure at its research and development sites in the United States and Europe. Lilly will leverage Spotfire's entire suite of Spotfire.net solutions to enable its scientists and researchers to rapidly access, analyze, and share data, collaborating across teams, departments, and geographies. The implementation is expected to accelerate the Company's drug discovery and development process, enabling faster and more informed decisions.

Key Takeaways:

  • Eli Lilly will deploy Spotfire.net solutions at all research and development sites in the United States and across Europe.
  • The partnership aims to accelerate the Company's drug discovery and development process by enabling faster and more informed decisions.
  • Spotfire's decision analytics platform and applications will be used to empower scientists and researchers to rapidly access, analyze, and share data.
  • The implementation will enable collaboration across teams, departments, and geographies.
  • Spotfire's solutions will be integrated into Lilly's intranet strategy to support its research and development efforts.
  • The partnership with Spotfire is expected to help Lilly establish a common platform for data access, analysis, and sharing, leading to long-term success in making rapid compound decisions.
  • The implementation is part of Lilly's strategy to improve the efficiency, speed, and accuracy of its decision-making processes.

Statistics:

  • Lilly is the 22nd company to partner with Spotfire.
  • Spotfire's solutions are currently in use at each of the top 25 pharmaceutical companies worldwide.
  • Over 80 biotechnology companies utilize Spotfire's solutions.
  • Spotfire's decision analytics software is used by thousands of scientists and researchers worldwide.
  • Lilly has thousands of scientists and researchers working globally.
  • Spotfire's platform and software tools will support Lilly's research and development efforts inaccelerating drug discovery and development.

Sources:

  • "Pharmaceutical Leader Eli Lilly Chooses Spotfire to Accelerate Research and Development." Business Wire. 22 Aug. 2000.
  • "Spotfire, Inc." About Spotfire. n.d.
  • "Spotfire, Inc." Press. n.d.

Read more